We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Vaccinex Announces Antibody Collaboration with Schering
News

Vaccinex Announces Antibody Collaboration with Schering

Vaccinex Announces Antibody Collaboration with Schering
News

Vaccinex Announces Antibody Collaboration with Schering

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Vaccinex Announces Antibody Collaboration with Schering"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Vaccinex, Inc. has announced that it has entered into research collaboration with Schering AG to identify disease targets and potentially develop therapeutic antibodies for the treatment of certain cancers.

Vaccinex will receive a technology access fee and research funding and is eligible for milestone payments and royalties.

Following the initial research phase, Vaccinex may receive certain options to co-develop a selected cancer product with Schering AG.

Dr. Maurice Zauderer, President and CEO of Vaccinex commented, "We are very excited about applying our proprietary technologies to validate several of Schering AG's oncology targets as well as to have an opportunity to collaborate in co-developing a promising cancer product."

"We are especially pleased to be working together with an accomplished pharmaceutical partner like Schering on the discovery and development of new and innovative treatments for cancer and other diseases."

Advertisement